Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Targeting of albumin-embedded paclitaxel nanoparticles to tumors.

Karmali PP, Kotamraju VR, Kastantin M, Black M, Missirlis D, Tirrell M, Ruoslahti E.

Nanomedicine. 2009 Mar;5(1):73-82. doi: 10.1016/j.nano.2008.07.007. Epub 2008 Oct 1.

PMID:
18829396
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.

Feng Z, Zhao G, Yu L, Gough D, Howell SB.

Cancer Chemother Pharmacol. 2010 Apr;65(5):923-30. doi: 10.1007/s00280-009-1099-1. Epub 2009 Aug 15.

PMID:
19685054
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.

Koo H, Min KH, Lee SC, Park JH, Park K, Jeong SY, Choi K, Kwon IC, Kim K.

J Control Release. 2013 Dec 28;172(3):823-31. doi: 10.1016/j.jconrel.2013.08.297. Epub 2013 Sep 11.

PMID:
24035978
[PubMed - indexed for MEDLINE]
4.

LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.

Wang Z, Yu Y, Ma J, Zhang H, Zhang H, Wang X, Wang J, Zhang X, Zhang Q.

Mol Pharm. 2012 Sep 4;9(9):2646-57. doi: 10.1021/mp3002107. Epub 2012 Aug 13.

PMID:
22853186
[PubMed - indexed for MEDLINE]
5.

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.

Desai NP, Trieu V, Hwang LY, Wu R, Soon-Shiong P, Gradishar WJ.

Anticancer Drugs. 2008 Oct;19(9):899-909. doi: 10.1097/CAD.0b013e32830f9046.

PMID:
18766004
[PubMed - indexed for MEDLINE]
6.

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.

Swaminathan SK, Roger E, Toti U, Niu L, Ohlfest JR, Panyam J.

J Control Release. 2013 Nov 10;171(3):280-7. doi: 10.1016/j.jconrel.2013.07.014. Epub 2013 Jul 18.

PMID:
23871962
[PubMed - indexed for MEDLINE]
7.

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.

Yu DH, Lu Q, Xie J, Fang C, Chen HZ.

Biomaterials. 2010 Mar;31(8):2278-92. doi: 10.1016/j.biomaterials.2009.11.047. Epub 2010 Jan 6.

PMID:
20053444
[PubMed - indexed for MEDLINE]
8.

18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.

Sun X, Yan Y, Liu S, Cao Q, Yang M, Neamati N, Shen B, Niu G, Chen X.

J Nucl Med. 2011 Jan;52(1):140-6. doi: 10.2967/jnumed.110.080606. Epub 2010 Dec 13. Erratum in: J Nucl Med. 2012 Nov;53(11):1824.

PMID:
21149494
[PubMed - indexed for MEDLINE]
Free Article
9.

A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases.

Ernsting MJ, Murakami M, Undzys E, Aman A, Press B, Li SD.

J Control Release. 2012 Sep 28;162(3):575-81. doi: 10.1016/j.jconrel.2012.07.043. Epub 2012 Aug 10.

PMID:
22967490
[PubMed - indexed for MEDLINE]
10.

Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.

Passarella RJ, Spratt DE, van der Ende AE, Phillips JG, Wu H, Sathiyakumar V, Zhou L, Hallahan DE, Harth E, Diaz R.

Cancer Res. 2010 Jun 1;70(11):4550-9. doi: 10.1158/0008-5472.CAN-10-0339. Epub 2010 May 18.

PMID:
20484031
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.

Laakkonen P, Akerman ME, Biliran H, Yang M, Ferrer F, Karpanen T, Hoffman RM, Ruoslahti E.

Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6. Epub 2004 Jun 14.

PMID:
15197262
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice.

Hamzah J, Kotamraju VR, Seo JW, Agemy L, Fogal V, Mahakian LM, Peters D, Roth L, Gagnon MK, Ferrara KW, Ruoslahti E.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7154-9. doi: 10.1073/pnas.1104540108. Epub 2011 Apr 11.

PMID:
21482787
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Transtumoral targeting enabled by a novel neuropilin-binding peptide.

Roth L, Agemy L, Kotamraju VR, Braun G, Teesalu T, Sugahara KN, Hamzah J, Ruoslahti E.

Oncogene. 2012 Aug 16;31(33):3754-63. doi: 10.1038/onc.2011.537. Epub 2011 Dec 19.

PMID:
22179825
[PubMed - indexed for MEDLINE]
14.

Radiolabeling LyP-1 peptide and preliminary biodistribution evaluation in mice bearing MDA-MB-435 xenografts.

Yu MM, Wang RF, Chen YH, Zhou HZ, Deng XH.

Chin Med J (Engl). 2013 Feb;126(3):471-5.

PMID:
23422109
[PubMed - indexed for MEDLINE]
Free Article
15.

Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel(TM).

Madaan A, Singh P, Awasthi A, Verma R, Singh AT, Jaggi M, Mishra SK, Kulkarni S, Kulkarni H.

Clin Transl Oncol. 2013 Jan;15(1):26-32. doi: 10.1007/s12094-012-0883-2. Epub 2012 Jul 24.

PMID:
22855169
[PubMed - indexed for MEDLINE]
16.

Protein nanoparticles as drug carriers in clinical medicine.

Hawkins MJ, Soon-Shiong P, Desai N.

Adv Drug Deliv Rev. 2008 May 22;60(8):876-85. doi: 10.1016/j.addr.2007.08.044. Epub 2008 Feb 7. Review.

PMID:
18423779
[PubMed - indexed for MEDLINE]
17.

Hybrid nanocrystals: achieving concurrent therapeutic and bioimaging functionalities toward solid tumors.

Zhao R, Hollis CP, Zhang H, Sun L, Gemeinhart RA, Li T.

Mol Pharm. 2011 Oct 3;8(5):1985-91. doi: 10.1021/mp200154k. Epub 2011 Aug 10.

PMID:
21812439
[PubMed - indexed for MEDLINE]
18.

Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.

Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S.

Neoplasia. 2011 Apr;13(4):327-38.

PMID:
21472137
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer.

Milane L, Duan Z, Amiji M.

PLoS One. 2011;6(9):e24075. doi: 10.1371/journal.pone.0024075. Epub 2011 Sep 8.

PMID:
21931642
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.

Hu Q, Gao X, Kang T, Feng X, Jiang D, Tu Y, Song Q, Yao L, Jiang X, Chen H, Chen J.

Biomaterials. 2013 Dec;34(37):9496-508. doi: 10.1016/j.biomaterials.2013.09.001. Epub 2013 Sep 17.

PMID:
24054848
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk